Xavier de Mollerat du Jeu

Thermo Fisher Scientific (United States) — United States

Medicine · Health Sciences

8h-index1.0kcitations28works4.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(15), Viral Infectious Diseases and Gene Expression in Insects(10), CRISPR and Genetic Engineering(5), Virus-based gene therapy research(4), Liver Disease Diagnosis and Treatment(3)

Publications27 total

Accelerating CAR T cell manufacturing with an automated next-day process
Current Research in Translational Medicine·2024· 7 cited
Accelerating CAR T cell manufacturing with an automated next-day process
2024· 3 citedOpen Access
SCALABLE SOLUTIONS FOR EXPANSION OF NON-VIRALLY GENERATED CAR T CELLS
Cytotherapy·2024
AN AUTOMATED 24-HOUR CAR T MANUFACTURING PROCESS
Cytotherapy·2024· 2 cited
Development of a robotic cluster for automated and scalable cell therapy manufacturing
Cytotherapy·2024· 9 citedOpen Access
Development of a robotic cluster for automated and scalable cell therapy manufacturing
2023· 1 citedOpen Access
Empowering the future of cell therapy: leveraging partnerships to support advancement
Cell and Gene Therapy Insights·2023
Implementing a closed cell therapy manufacturing process through strategic collaboration
Cell and Gene Therapy Insights·2023
Key factors to consider for successful cell therapy manufacturing: a case study
Cell and Gene Therapy Insights·2022Open Access
Ionizable liposomal siRNA therapeutics enables potent and persistent treatment of Hepatitis B
Signal Transduction and Targeted Therapy·2022· 49 citedOpen Access
Rotea: a closed and automated instrument for efficient cell isolation, washing and conentration in cell therapy workflows
Cytotherapy·2020· 4 cited
Enabling the advancement of non-viral CRISPR-based cell therapy with a new Large-scale electroporation platform
Cytotherapy·2020· 1 cited
Development of a new semi-automated closed modular system for CAR-T cell therapy manufacturing
Cytotherapy·2020
Neutrophils contribute to spontaneous resolution of liver inflammation and fibrosis via microRNA-223
Journal of Clinical Investigation·2019· 256 citedOpen Access
Large scale serum free suspension lentiviral production for cell and gene therapy application
Cytotherapy·2019
Closed and automated cell processing using roteaTM to advance cell therapy
Cytotherapy·2019
Addressing the Challenges of Commercial-Scale Manufacture of Viral Vectors for CAR-T Therapies
Cell and Gene Therapy Insights·2018· 1 cited
Non-viral and viral delivery solutions for next generation cell therapy
The Journal of Immunology·2018
Optimization of Gene Editing in Human Primary T Cells with Neon® Transfection System
The Journal of Immunology·2017
462. Serum Free Clinical Grade Large Scale Lentiviral Production System for Gene Therapy Application
Molecular Therapy·2016· 1 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Ariel E. Feldstein(3), Xin Yu(3), Namritha Ravinder(3), Danny Hayoun(3), Jorge Padilla(3), Yongchang Ji(3), Nektaria Andronikou(3), Casey D. Johnson(2), Akiko Eguchi(2), Nektaria Andronikou(2), Xiquan Liang(2), Alice Melocchi(2), Brigitte Schmittlein(2), Alexis Jones(2), Yasmine Ainane(2), Ali A. Rizvi(2), Darius K.‐S. Chan(2), Elaine Dickey(2), Kelsey Pool(2), Kenny Harsono(2)